Overview
- Overton’s path to confirmation narrowed this week as returning Senate Republicans left her needing every GOP vote on the Health, Education, Labor and Pensions Committee to advance.
- She faces attacks from both MAHA-aligned activists who say she blocked their food and pesticide priorities and conservative critics who cite her confirmation hearing statements on vaccines and the abortion-pill review.
- Politico reported a $500,000 ad buy by Americans for Contraception targeting key GOP senators to oppose her, an outside pressure effort meant to sway fence‑sitting votes.
- The White House has a fallback plan to place former FDA deputy Sara Brenner in charge if Overton is not confirmed, and the agency is currently led by Acting Commissioner Kyle Diamantas.
- The outcome matters for FDA policy because a failed confirmation would prolong leadership uncertainty at the agency and affect pending decisions on vaccines, contraception and pesticide regulation.